Abstract Book 2010 - CIMT Annual Meeting
Abstract Book 2010 - CIMT Annual Meeting
Abstract Book 2010 - CIMT Annual Meeting
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
006 Bernard | Therapeutic vaccination<br />
Investigating the impact of autophagy modulation on dendritic<br />
cell cancer vaccines<br />
Dannie Bernard 1 , Julian J. Lum 2 , Yonghong Wan 1 and Jonathan L. Bramson 1<br />
1 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, L8N 3Z5, Canada<br />
2 Deeley Research Center, BC Cancer Agency, Vancouver Island, British Columbia, V8R 6V5, Canada<br />
42<br />
Autophagy has been linked to extended survival<br />
when cells are faced with cellular stress. Ex-vivo<br />
derived dendritic cells (DCs) undergo substantial<br />
stress upon antigen loading and in-vivo delivery<br />
and the importance of autophagy in protecting<br />
DCs from these stresses is poorly understood.<br />
We have employed 2 strategies to investigate the<br />
impact of autophagy on DC vaccines. In the first<br />
case, we employed rapamycin as an inducer of autophagy<br />
in an effort to precondition the DCs prior<br />
to infection with recombinant adenovirus (Ad)<br />
and recombinant vesicular stomatitis virus (VSV).<br />
Kinetic analyses showed that rapamycin was effective<br />
at inhibiting its target mTOR within 5 hours of<br />
treatment and the inhibition was maintained for at<br />
least 24 hours post-transduction. Preconditioning<br />
of DCs with rapamycin did not affect infectivity,<br />
as measured by GFP expression, nor did it affect<br />
maturation, defined by MHC II, CD40, CD86, IL-12<br />
and TNF-a expression. However, we noted a 10-fold<br />
reduction in type I interferon secretion following<br />
VSV transduction, but not Ad transduction. We<br />
are currently conducting in-vivo experiments with<br />
rapamycin-preconditioned DC vaccines and results<br />
will be discussed at the meeting. In the second<br />
case, we have investigated the role of basal autophagy<br />
in the context of DC vaccination. We have<br />
crossed ATG5fl/fl mice with CD11c-Cre mice to generate<br />
conditional knockout mice in which DCs are<br />
autophagy-deficient. Results obtained thus far from<br />
in-vitro phenotyping experiments of virally trans-<br />
duced DCs indicate that autophagy deficiency does<br />
not significantly impact maturation of the cells.<br />
The importance of autophagy following delivery of<br />
DC vaccines still remains to be determined. This<br />
work was supported by grants from CIHR, OCRN<br />
and TFF.